TickerFacts.

Exagen Inc. (XGN): Revenue

Annual figures by period end, from SEC filings.

$66.58M
Year ended 2025-12-31
$71.12M
Trailing 12 months to 2026-06-30
+13.5%
3-year compound annual growth
+9.7%
5-year compound annual growth
2018-12-31: $32.44M2019-12-31: $40.39M2020-12-31: $41.98M2021-12-31: $48.30M2022-12-31: $45.56M2023-12-31: $52.55M2024-12-31: $55.64M2025-12-31: $66.58M$66.58M
2018-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$66.58M+19.7%2026-03-10, From 2025-01-01
2024-12-31$55.64M+5.9%2026-03-10, From 2024-01-01
2023-12-31$52.55M+15.3%2025-03-11, From 2023-01-01
2022-12-31$45.56M-5.7%2024-03-18, From 2022-01-01
2021-12-31$48.30M+15.1%2023-03-20, From 2021-01-01
2020-12-31$41.98M+3.9%2022-03-22, From 2020-01-01
2019-12-31$40.39M+24.5%2021-03-16, From 2019-01-01
2018-12-31$32.44Mn/a2020-03-25, From 2018-01-01

Revenue at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Exagen Inc. (XGN)2025-12-31$66.58M+19.7%
Personalis, Inc. (PSNL)2025-12-31$69.65M-17.7%
Biodesix Inc (BDSX)2025-12-31$88.50M+24.1%
CapForce Inc. (CFOR)2025-12-31$30.20M+481.2%
GRAIL, Inc. (GRAL)2025-12-31$147.17M+17.2%
American Shared Hospital Services (AMS)2025-12-31$28.08M-0.9%
BillionToOne, Inc. (BLLN)2025-12-31$305.11M+100.0%
Fulgent Genetics, Inc. (FLGT)2025-12-31$322.67M+13.8%
Castle Biosciences Inc (CSTL)2025-12-31$344.23M+3.7%

Compare XGN, PSNL, BDSX, CFOR side by side · Screen every company in Services-Medical Laboratories ↗